In short
Cardiometabolic risk is the cluster that drives heart attack, stroke and type 2 diabetes: blood pressure, lipids, blood sugar, weight and kidney function.
The number that matters is your calculated 10 year risk, and it sorts you into one of four groups.
- Under 3 per cent low. Lifestyle, recheck in four to six years
- 3 to under 5 per cent borderline. Risk enhancers and lifetime risk decide
- 5 to under 10 per cent intermediate. Statin usually suggested
- 10 per cent or more high. Treat, no further stratification needed
Condition Overview
What is being measured?
The traditional risk factors are smoking, high blood pressure, diabetes, abnormal lipids and obesity. A baseline lipid panel covers total, LDL and HDL cholesterol and triglycerides.
Modern calculators add kidney function and body mass index, and optionally urine albumin and HbA1c. That is deliberate: kidney function turns out to carry real predictive weight.
Which risk group are you in?
| Low, under 3 per cent | Lifestyle. Most people gain nothing from a statin. Recheck in four to six years, sooner if something changes. |
| Borderline, 3 to under 5 | Risk enhancers and 30 year risk decide. A calcium score often settles it. |
| Intermediate, 5 to under 10 | Statin usually suggested, especially at the higher end. Yearly review. |
| High, 10 or more | Treat. No further stratification needed. |
What are risk enhancers?
These are factors that raise your real risk but are missing from some calculators. They do not change the number, they change how the number is read.
In diabetes specifically, the recognised enhancers are long duration, at least 10 years for type 2 and 20 for type 1, albuminuria of 30 mcg per mg creatinine or more, kidney function below 60, retinopathy and neuropathy.
Why is 30 year risk sometimes calculated?
Because a 40 year old can have a genuinely low 10 year risk and a high lifetime risk. Between 30 and 59, if the 10 year figure is low or borderline, the 30 year figure is worked out as well.
People with low 10 year but 30 year risk of 10 per cent or more have more subclinical atherosclerosis and more events. In a cohort of nearly 28,000 middle aged women, CRP, LDL and lipoprotein(a) each independently predicted events at 30 years, and the effects were additive.
When do calculators get it wrong?
- LDL of 190 mg/dL or above. Very high risk regardless. This needs assessment for familial hypercholesterolaemia.
- Familial hypercholesterolaemia. Calculators do not apply at all.
- Type 1 diabetes. Underestimated by most calculators, even under 40.
- Type 2 diabetes. Underestimated by calculators that leave out kidney function, albuminuria and glucose control.
- Plaque already seen on a scan done for something else. That raises risk in a graded way and is not ignored.
When to See a Doctor
- You are 30 or older and have never had your cardiovascular risk formally calculated
- Blood pressure, cholesterol or blood sugar has come back abnormal on a routine check
- Weight has increased and you want to know what it is doing to your risk rather than just your appearance
- You have diabetes and want the risk enhancers checked, not just your HbA1c
- You have been offered a statin and want to understand whether you actually need one
- Chest pain or pressure on exertion, or new breathlessness
- LDL cholesterol of 190 mg/dL or above, which needs assessment for familial hypercholesterolaemia
- Blood pressure repeatedly very high, which needs treating rather than monitoring
How Dr. Felix Assesses This
-
1
History and examination
Traditional risk factors, diet, physical activity, and the risk enhancers that calculators leave out. Family history of early heart disease is recorded even where the calculator ignores it.
-
2
Baseline bloods
Full lipid panel including triglycerides and LDL, glucose or HbA1c, and kidney function with urine albumin where relevant. These feed the calculator and stand on their own.
-
3
The calculation
A validated 10 year risk, plus a 30 year figure if you are 30 to 59 and the 10 year result is low or borderline.
-
4
The plan and the interval
Lifestyle in every group. Statin, blood pressure treatment and aspirin where the risk category supports it. Recheck at four to six years if low, yearly if borderline or above.
Treatment Options
Precision Medicine Program
What does precision actually mean here? Three concrete things: using a risk model that fits you, adding the factors your…
View Treatment
Longevity Consultation
What happens in the appointment? Roughly half of it is history. What you do, how you sleep, how much you…
View Treatment
Personalized Longevity Plan
What actually makes a plan personal? Not a longer panel. The four inputs that change the plan are your calculated…
View Treatment
Healthy Ageing Program
Where should someone sedentary start? Lower than they expect. In a meta analysis of prospective cohorts covering over 135,000 adults,…
View Treatment
Why Early Treatment Can Matter
Why does it matter to catch this early?
Because atherosclerosis begins early in life and the changes accumulate quietly. Risk assessment is started at 20, or the first medical contact after that, even though calculators are not used until 30.
Between 20 and 29, the assessment is qualitative: risk factors, lipids and enhancers. Ten year risk in that age group is almost always very low, which is exactly why the number is unhelpful and the pattern is not.
What actually reduces risk?
- Stopping smoking. Across 49 trials, counselling raised quit rates by more than half, and adding medication raised them further
- Blood pressure treatment. Backed by randomised trials
- Lipid lowering. Backed by randomised trials, with the intensity matched to your risk band
- Weight and activity. Both feed directly into the calculators
An honest caution about diabetes
Tight blood sugar control alone did not reduce cardiovascular disease or death better than looser control in three randomised trials. That surprised a lot of people.
Treating the other risk factors did. In one trial, multifactorial treatment halved cardiovascular disease and death over 13 years, and at 21 years the treated group had lived a median of 7.9 years longer.
What if the picture is unclear?
At borderline or intermediate risk, a coronary calcium score often resolves it, in either direction. It can move you up or down, and both outcomes are useful.
Why Early Treatment Can Matter
Why does it matter to catch this early?
Because atherosclerosis begins early in life and the changes accumulate quietly. Risk assessment is started at 20, or the first medical contact after that, even though calculators are not used until 30.
Between 20 and 29, the assessment is qualitative: risk factors, lipids and enhancers. Ten year risk in that age group is almost always very low, which is exactly why the number is unhelpful and the pattern is not.
What actually reduces risk?
- Stopping smoking. Across 49 trials, counselling raised quit rates by more than half, and adding medication raised them further
- Blood pressure treatment. Backed by randomised trials
- Lipid lowering. Backed by randomised trials, with the intensity matched to your risk band
- Weight and activity. Both feed directly into the calculators
An honest caution about diabetes
Tight blood sugar control alone did not reduce cardiovascular disease or death better than looser control in three randomised trials. That surprised a lot of people.
Treating the other risk factors did. In one trial, multifactorial treatment halved cardiovascular disease and death over 13 years, and at 21 years the treated group had lived a median of 7.9 years longer.
What if the picture is unclear?
At borderline or intermediate risk, a coronary calcium score often resolves it, in either direction. It can move you up or down, and both outcomes are useful.
What treatment achieves
In diabetes, multifactorial risk factor treatment halved cardiovascular events and death over 13 years and added a median of 7.9 years of life at 21 years.
What is at stake
Heart attack, stroke, peripheral artery disease and aortic aneurysm. Coronary heart disease alone causes about half of cardiovascular deaths worldwide.
A number, not a lecture
One calculation puts you in one of four groups, and each group has a defined answer. You leave knowing which one you are in.
Cost & Consultation Investment
The consultation and the blood panel are quoted separately and you are told both before anything is ordered. The panel is the standard one that feeds a validated risk calculator rather than a long list of extras. Any further test, such as a calcium score, is only suggested where the result would change the plan, and is quoted before it is arranged.
Frequently Asked Questions
There is no single good number. What matters is which of the four risk bands you fall into, because each has a different recommendation, and where you sit in that band.
Below 3 per cent, usually not. At 5 to 10 per cent, usually yes, especially at the higher end. Between 3 and 5, it depends on risk enhancers and lifetime risk, and a calcium score often settles it.
At borderline risk the bleeding risk usually outweighs the benefit. It is a shared decision at intermediate and high risk, and is used under 70 when the calcium score is 100 or more.
Feeling fine is the normal state until something happens. LDL of 190 mg/dL or above puts you at very high risk regardless of any calculator and needs assessment for an inherited cause.
Every four to six years if you are low risk, sooner if a risk factor changes. Yearly at borderline or above, and sooner again if you start medication.
Yes in the discussion, even though some calculators leave it out. A well documented family history of early heart disease informs the decision even where it does not move the number.
Calculators are built on specific populations, so the one used should be the one validated for you. No single model fits everyone, and that is taken into account rather than ignored.
Evidence
Where this information comes from
Every figure on this page is taken from the sources below. All of them are free to read, so you can check them yourself.
- Obesity and overweight
- Obesity: identification, assessment and management
- Semaglutide for managing overweight and obesity
- Cardiovascular diseases
This page is general medical information and does not replace a personal consultation. Trial results are averages across large groups, not a prediction for any one person.